Autologous mesenchymal stem cell therapy (University Hospitals Cleveland Medical Center)

N/A

Report date: 2023/01/12 15:30:09

Base Information

Drug NameAutologous mesenchymal stem cell therapy (University Hospitals Cleveland Medical Center)
Drug Alias Name自体间充质干细胞疗法Autologous Mesenchymal Stem Cellsautologous bone marrow-derived MSCs
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsMusculoskeletal PainOsteoarthritis, KneeCartilage Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Hospitals Cleveland Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Hospitals Cleveland Medical Center
Inactive CompaniesN/A
Active IndicationsMusculoskeletal PainOsteoarthritis, KneeCartilage Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A